Linee guida per la compilazione del dossier a supporto della domanda di rimborsabilità e prezzo di un medicinale ai sensi del d.m. 2 agosto 2019. Versione 1.0 - 2020. Online https://www.aifa.gov.it/documents/20142/1307543/2021.01.22_estratto_linee_guida_sezione_E.pdf (Accessed March 2023)

Ravasio R, Girolomoni G, Gorla R. Analisi di budget impact del biosimilare di etanercept: lo scenario italiano. Glob Reg Health Technol Assess. 2018;5:1-12. https://doi.org/10.33393/grhta.2018.444

Basile M, Somaini L, Cicchetti A. Analisi di Budget Impact della formulazione depot di buprenorfina a rilascio prolungato per la gestione di pazienti affetti da disturbo da uso di oppiacei. Glob Reg Health Technol Assess. 2021;8:96-104. https://doi.org/10.33393/grhta.2021.2237

Bini C, Mennini FS, Marcellusi A, Paoletti M, Tomino C. Analisi di impatto di budget di un nuovo sistema di cura in pazienti affetti da malattia di Parkinson. Glob Reg Health Technol Assess. 2022;9:91-98. https://doi.org/10.33393/grhta.2022.2413

Mauskopf JA, Sullivan SD, Annemans L, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. Value Health. 2007;10(5):336-347. https://doi.org/10.1111/j.1524-4733.2007.00187.x PMID:17888098

Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.

Value Health. 2014 Jan-Feb;17(1):5-14. https://doi.org/10.1016/j.jval.2013.08.2291 PMID:24438712

Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008-1015. PMID:11095242

Giannarou L, Zervas E. Using Delphi technique to build consensus in practice. Int J Bus Sci Appl Manag. 2014;9:65-82.

Mauskopf J. Stephanie R. Earnshaw, Anita Brogan, Sorrel Wolowacz, Thor-Henrik Brodtkorb. Budget-Impact Analysis of Health Care Interventions. A Practical Guide. Springer International Publishing AG; 2017, https://doi.org/10.1007/978-3-319-50482-7.

Tastle WJ, Wierman MJ, Dumdum UR. Ranking ordinal scales using the consensus measure. Issues Inf Syst. 2005;6(2):96-102.

Drummond M, Griffin A, Tarricone R. Economic evaluation for devices and drugs--same or different? Value Health. 2009;12(4):402-404. https://doi.org/10.1111/j.1524-4733.2008.00476_1.x PMID:19138306

Taylor RS, Iglesias CP. Assessing the clinical and cost-effectiveness of medical devices and drugs: are they that different? Value Health. 2009;12(4):404-406. PMID:19138305 https://doi.org/10.1111/j.1524-4733.2008.00476_2.x PMID:19138305

Tarricone R, Callea G, Ogorevc M, Prevolnik Rupel V. Improving the Methods for the Economic Evaluation of Medical Devices. Health Econ. 2017;26(suppl 1):70-92. PMID:28139085 https://doi.org/10.1002/hec.3471 PMID:28139085

Gazzetta Ufficiale della Repubblica Italiana. Serie Generale n. 300 del 23.12.1996. Online https://www.gazzettaufficiale.it/eli/gu/1996/12/23/300/sg/pdf (Accessed March 2023)